Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Valeo Pharma (VPH)

Valeo Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:VPH
DateTimeSourceHeadlineSymbolCompany
25/04/202422:55PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERSTSX:VPHValeo Pharma Inc
09/04/202412:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
22/03/202411:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
14/03/202421:29PR Newswire (Canada)VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTSTSX:VPHValeo Pharma Inc
07/03/202412:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
13/02/202412:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGESTSX:VPHValeo Pharma Inc
02/02/202422:03PR Newswire (Canada)VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LPTSX:VPHValeo Pharma Inc
29/01/202422:48PR Newswire (Canada)VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023TSX:VPHValeo Pharma Inc
22/01/202412:00PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
20/11/202312:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVESTSX:VPHValeo Pharma Inc
07/11/202312:15PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
04/10/202312:00PR Newswire (Canada)VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIESTSX:VPHValeo Pharma Inc
27/09/202312:00PR Newswire (Canada)VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
27/09/202312:00PR Newswire (Canada)VALEO PHARMA CONCLUT UNE ENTENTE DE FACILITÉ DE CRÉDIT DE 5 MILLIONS $ AVEC ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
14/09/202301:01PR Newswire (Canada)VALEO PHARMA ANNONCE DES REVENUS RECORDS POUR LE TROISIÈME TRIMESTRE DE 2023TSX:VPHValeo Pharma Inc
14/09/202300:44PR Newswire (Canada)VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUESTSX:VPHValeo Pharma Inc
07/09/202312:00PR Newswire (Canada)VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
01/09/202300:11PR Newswire (Canada)Investissement Québec conclut un placement privé dans Valeo Pharma Inc.TSX:VPHValeo Pharma Inc
31/08/202323:27PR Newswire (Canada)VALEO PHARMA CONCLUT UN FINANCEMENT DE 4,5 MILLIONS $TSX:VPHValeo Pharma Inc
31/08/202323:10PR Newswire (Canada)VALEO PHARMA CLOSES $4.5 MILLION FINANCINGTSX:VPHValeo Pharma Inc
22/06/202312:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTSTSX:VPHValeo Pharma Inc
07/06/202312:00PR Newswire (Canada)VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
25/05/202312:00PR Newswire (Canada)VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023TSX:VPHValeo Pharma Inc
28/04/202312:43PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS AND COMMITTEE APPOINTMENTSTSX:VPHValeo Pharma Inc
19/04/202312:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2023 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
15/03/202321:00PR Newswire (Canada)VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023TSX:VPHValeo Pharma Inc
09/03/202312:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
07/02/202312:00PR Newswire (Canada)VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBECTSX:VPHValeo Pharma Inc
26/01/202312:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTSTSX:VPHValeo Pharma Inc
25/01/202314:38PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
 Showing the most relevant articles for your search:TSX:VPH